Advertisement
ASMB vs NBTX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a Hold and NBTX is a StrongBuy.
Momentum Indicator for ASMB turns positive, indicating new upward trend
ASMB saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In 84 of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ASMB's RSI Indicator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for ASMB just turned positive on October 20, 2026. Looking at past instances where ASMB's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.
Following a +8.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASMB advanced for three days, in 215 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for ASMB moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
ASMB broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ASMB entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. ASMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.360) is normal, around the industry mean (3.498). P/E Ratio (16.468) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (5.568) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
NBTX in upward trend: price rose above 50-day moving average on November 09, 2026
NBTX moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 42 of 50 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for NBTX just turned positive on October 20, 2026. Looking at past instances where NBTX's MACD turned positive, the stock continued to rise in 37 of 45 cases over the following month. The odds of a continued upward trend are 82%.
The 10-day moving average for NBTX crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
Following a +7.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where NBTX advanced for three days, in 188 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for NBTX moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 22 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 53 cases where NBTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NBTX as a result. In 78 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The 50-day moving average for NBTX moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
NBTX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NBTX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-46.722) is normal, around the industry mean (3.498). P/E Ratio (-28.101) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (48.077) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. NBTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ASMB | NBTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 61 | |
SMR RATING 1..100 | 89 | 99 | |
PRICE GROWTH RATING 1..100 | 74 | 42 | |
P/E GROWTH RATING 1..100 | 97 | 27 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NBTX's Valuation (3) in the null industry is significantly better than the same rating for ASMB (84) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew significantly faster than ASMB’s over the last 12 months.
NBTX's Profit vs Risk Rating (61) in the null industry is somewhat better than the same rating for ASMB (100) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew somewhat faster than ASMB’s over the last 12 months.
ASMB's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as NBTX (99) in the null industry. This means that ASMB’s stock grew similarly to NBTX’s over the last 12 months.
NBTX's Price Growth Rating (42) in the null industry is in the same range as ASMB (74) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew similarly to ASMB’s over the last 12 months.
NBTX's P/E Growth Rating (27) in the null industry is significantly better than the same rating for ASMB (97) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew significantly faster than ASMB’s over the last 12 months.
| ASMB | NBTX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 74% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 82% |
| Advances ODDS (%) | 3 days ago 81% | 2 days ago 81% |
| Declines ODDS (%) | 10 days ago 86% | 10 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASMB’s FA Score shows that 0 FA rating(s) are green while NBTX’s FA Score has 2 green FA rating(s).
- ASMB’s FA Score: 0 green, 5 red.
- NBTX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASMB’s TA Score shows that 4 TA indicator(s) are bullish while NBTX’s TA Score has 4 bullish TA indicator(s).
- ASMB’s TA Score: 4 bullish, 5 bearish.
- NBTX’s TA Score: 4 bullish, 7 bearish.
Price Growth
ASMB (@Biotechnology) experienced а +7.18% price change this week, while NBTX (@Biotechnology) price change was +15.09% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
ASMB is expected to report earnings on Mar 25, 2027.
NBTX is expected to report earnings on Nov 17, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ASMB and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with EDIT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To ASMB | 1D Price Change % | ||
|---|---|---|---|---|
| ASMB | 100% | -2.02% | ||
| EDIT - ASMB | 44% Loosely correlated | -8.91% | ||
| ENTA - ASMB | 44% Loosely correlated | -2.18% | ||
| VYGR - ASMB | 43% Loosely correlated | -8.29% | ||
| IMMX - ASMB | 43% Loosely correlated | -2.57% | ||
| FDMT - ASMB | 42% Loosely correlated | -0.16% | ||
More | ||||
NBTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, NBTX has been loosely correlated with FDMT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NBTX jumps, then FDMT could also see price increases.
| Ticker / NAME | Correlation To NBTX | 1D Price Change % | ||
|---|---|---|---|---|
| NBTX | 100% | +2.62% | ||
| FDMT - NBTX | 34% Loosely correlated | -0.16% | ||
| SLDB - NBTX | 34% Loosely correlated | +2.14% | ||
| CLLS - NBTX | 34% Loosely correlated | -0.89% | ||
| ASMB - NBTX | 33% Loosely correlated | -2.02% | ||
| NAMS - NBTX | 33% Poorly correlated | +0.95% | ||
More | ||||